2025.07. 28 7月28日晚间，沪深两市多家上市公司发布公告，以下是第一财经对一些重要公告的汇总，供投资者 参考。 【品大事】 居然智家：实际控制人、董事长兼CEO汪林朋逝世 居然智家(000785)公告，公司董事会沉痛公告，公司收到公司实际控制人、董事长兼CEO汪林朋家 属的通知，汪林朋于2025年7月27日在家中不幸身故。汪林朋为公司实际控制人，其与一致行动人 北京居然之家投资控股集团有限公司、霍尔果斯慧鑫达建材有限公司合计持有公司43.93%股份。汪 林朋直接及间接持有的公司股份将按法律法规办理相关手续，公司将根据后续事项进展情况及时履行 信息披露义务。公司全体董事推举董事、执行总裁王宁暂代履行公司董事长、法定代表人、CEO、 董事会战略和投资委员会主任委员、董事会预算委员会主任委员职责。目前，公司董事会、监事会和 高级管理人员均正常履职，公司经营情况一切正常。 神农集团：终止2024年度向特定对象发行股票事项 恒鑫生活：拟不超过5.05亿元投建绿色可降解制品生产基地项目 恒鑫生活(301501)公告，公司及/或子公司拟以自有资金、银行贷款或其他融资方式，在安徽省合 肥市长丰县建设绿色可降解制品 ...

Key Points - The actual controller, chairman, and CEO of Juran Smart Home, Wang Linpeng, has passed away [1] - Jianghe Group's construction and decoration segment won contracts worth approximately 13.694 billion yuan in the first half of the year, representing a year-on-year increase of 6.29% [2] - Dele Shares plans to transfer 100% equity of Derui Mining to Fengyang Mining Investment [2] - Sichuan Chengyu led a consortium that won the bid for the G5 Jingkun Expressway expansion project from Chengdu to Ya'an [1] - Huai City Environmental Protection reported a net profit of 5.0204 million yuan in the first half of the year, a year-on-year decrease of 85.63% [2] - Awei Electronics intends to issue convertible bonds to raise no more than 1.901 billion yuan for the construction of a global R&D center [3] - The company Tianyi plans to participate in the e-enterprise network terminal production procurement project [1]

Group 1: Company Performance - WuXi AppTec reported a net profit of 8.561 billion yuan for the first half of the year, a year-on-year increase of 101.92% [1] - The company's revenue for the first half reached 20.799 billion yuan, reflecting a growth of 20.64% year-on-year [1] - WuXi AppTec plans to distribute a cash dividend of 3.5 yuan per share to all shareholders [1] - The company has revised its revenue forecast for the full year to between 42.5 billion and 43.5 billion yuan [1] - SANY Heavy Industry plans to issue non-financial corporate debt financing tools not exceeding 20 billion yuan to optimize its financing structure [1] Group 2: Film Industry Impact - Happiness Blue Sea announced that the film "Nanjing Photo Studio" has surpassed 412 million yuan in cumulative box office, exceeding 50% of the company's audited revenue for the most recent fiscal year [2] - The film's impact on the company's revenue is currently negligible as it is still in theaters [2] Group 3: Corporate Actions - Zhonghua Equipment plans to issue shares to acquire 100% equity of two companies, marking a significant asset restructuring [2] - Dahua Intelligent is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure [3] - Shiming Technology's actual controller and chairman has been placed under detention due to personal matters unrelated to the company [4] Group 4: Financial Performance - Ju Chen Co. reported a net profit growth of 43.5% for the first half of the year [6] - Qizheng Tibetan Medicine's net profit increased by 9.94% year-on-year [6] - China Minmetals' new contract value decreased by 19.1% year-on-year [6] - Huicheng Environmental's net profit declined by 85.63% year-on-year [6] Group 5: Mergers and Acquisitions - Kaishan Holdings plans to acquire a minority stake in SMGP for 3 million USD [6] - Zhonghua International intends to purchase 100% equity of Nantong Xingchen Composite Materials Co., Ltd. [6] - Xiangdian Co. plans to acquire a 12.5% stake in Tongda Electromagnetic Energy for 208 million yuan [6]

Core Viewpoint - The company announced a semi-annual distribution plan for 2025, proposing a cash dividend of 0.2 yuan per share, totaling approximately 25.26 million yuan, which represents 26.48% of its net profit, marking the 16th distribution since its listing [2]. Financial Performance - The company reported a revenue of 1.776 billion yuan for the latest half-year, reflecting a year-on-year decline of 13.75% [2]. - The net profit for the period was approximately 95.39 million yuan, down 39.54% year-on-year, with basic earnings per share at 0.0755 yuan [2]. Shareholder Returns - The distribution history shows a trend of varying cash dividends over the years, with the latest proposed dividend being lower than previous distributions, such as 1.15 yuan per share in December 2023 and 1.4 yuan per share in December 2022 [2]. - The company has consistently provided dividends since its listing, with the latest proposal being the 16th distribution [2]. Market Activity - The stock experienced a net outflow of 21.15 million yuan in principal funds today, with a total net outflow of 143 million yuan over the past five days [3]. - The latest margin financing balance for the stock is 530 million yuan, which has increased by 63.83 million yuan, representing a growth of 13.69% over the past five days [4].

Core Viewpoint - Multiple listed companies in the Shanghai and Shenzhen markets announced significant updates, reflecting changes in capital raising strategies, new business ventures, and financial performance for the first half of the year [1][2]. Company Announcements - Shennong Group has decided to terminate its plan for a specific stock issuance for the 2024 fiscal year due to changes in market conditions and overall development strategy, and will withdraw its application from the Shanghai Stock Exchange [3]. - Xizhuang Co. plans to establish a joint venture focused on sustainable aviation fuel, contributing 1.1 million yuan to a total registered capital of 5 million yuan, aiming to expand its technology into new application areas [4]. - Shandong Gold's subsidiary, Shanjin International, intends to issue H-shares and apply for listing on the Hong Kong Stock Exchange, considering market conditions and shareholder interests [5]. - Lopuskin plans to acquire a 38.38% stake in Wuhan Senfori Technology Co. for 8.82 million yuan, enhancing its position in the industrial non-destructive testing equipment sector [6]. - Hengxin Life intends to invest up to 505 million yuan in a biodegradable product production base in Hefei, Anhui Province [7]. - Hetai Machinery confirmed it has not participated in the Yarlung Zangbo River downstream hydropower project, which is still in the early stages of construction [8]. - Kaishan Co. plans to acquire a 5% stake in Sorik Marapi Geothermal Limited in Indonesia for 3 million USD, aiming for full ownership [9][10]. Financial Performance - WuXi AppTec reported a net profit of 8.561 billion yuan for the first half of 2025, a year-on-year increase of 101.92%, with revenue of 20.799 billion yuan, up 20.64% [12]. - Sujiao Technology's net profit decreased by 39.54% year-on-year to 95.3948 million yuan, with revenue down 13.75% to 1.776 billion yuan [13]. - Aide Biology achieved a net profit of 189 million yuan, a 31.41% increase year-on-year, with revenue of 579 million yuan, up 6.69% [14]. Major Contracts - Weiye Co. won a construction project worth approximately 522 million yuan for the Huafa Xiangshan Lake project [16]. - Fosun Pharma's subsidiary signed a licensing agreement for a drug targeting Alzheimer's disease, gaining rights for development and commercialization in China and Hong Kong [17]. - Huafeng Aluminum plans to sign a raw material purchase contract with Yulin New Materials, with an expected total value exceeding 7.2 billion yuan over the contract period from 2025 to 2029 [18]. Shareholding Changes - Suneng Co.'s shareholder, Jiaoyin Investment, plans to reduce its stake by up to 1%, amounting to no more than 6.8888 million shares [20]. - Shengyang Technology's shareholder, Guojiao Beidou, also intends to reduce its stake by up to 1%, equating to no more than 414.98 million shares [22]. Fundraising Activities - Huhua Co. plans to raise up to 586 million yuan through a private placement to fund various projects, including the automation of explosive production lines and warehouse systems [24].

Group 1 - Changhua Group received a product purchase contract for carbon-ceramic brake discs, with a total sales amount expected to exceed 100 million yuan over a 5-year lifecycle, starting mass production in Q2 2026 [1] - Zhongke Environmental reported a net profit of 196 million yuan for the first half of 2025, a year-on-year increase of 19.83%, with revenue of 848 million yuan, up 4.48% [1] - WuXi AppTec's net profit for the first half of 2025 grew by 101.92% to 8.561 billion yuan, with revenue of 20.799 billion yuan, a 20.64% increase [1][2] - Sujiao Technology's net profit decreased by 39.54% to 95.39 million yuan, with revenue down 13.75% to 1.776 billion yuan [1] - Jucheng Co. reported a net profit of 205 million yuan, a significant increase of 43.5%, with revenue of 575 million yuan, up 11.69% [1] Group 2 - Sanxiang New Materials plans to invest up to 300 million yuan in a zirconium-hafnium separation project, with a production capacity of 20,000 tons [1] - Koweil received government subsidies totaling 4.9752 million yuan, accounting for 10.14% of its audited net profit [1] - Xinhua Medical obtained two Class II medical device registration certificates for digital X-ray machines [1] - Huanxu Electronics reported a net profit of 638 million yuan, down 18.66%, with total revenue of 27.214 billion yuan, a slight decrease of 0.63% [1] - Zhenhua Co.'s general manager was fined 100,000 yuan for violations related to stock trading by his child [1] Group 3 - Huafeng Aluminum signed a raw material purchase contract worth over 7.2 billion yuan for a five-year period, committing to purchase at least 360,000 tons of raw materials [1] - Hongxin Technology received a project designation letter and procurement contract from a major domestic automotive brand [1] - Meihe Co. obtained a patent for a device used in supporting automatic flipping on conveyor lines in the automotive manufacturing sector [1] - Xin Hongye's subsidiary won a bid for an electrical penetration project worth 40.8831 million yuan [1] - Fuan Pharmaceutical's subsidiary received a drug registration certificate for an injection used in liver disease treatment [1] Group 4 - Tianzhong Precision's subsidiary's bankruptcy liquidation application was accepted by the court due to insufficient assets to cover debts [1] - Zhonghong Medical's subsidiary received medical device registration for infusion pumps and information collection systems [1] - Keda Li's subsidiary completed a capital increase, raising its registered capital from 200 million yuan to 400 million yuan [1] - Xingye Technology applied for a credit limit of 372 million yuan from Guangfa Bank [1] - Hengrui Medicine signed a collaboration agreement with GSK, involving a potential total payment of approximately 12 billion USD based on project milestones [1]

证券代码：300284 证券简称：苏交科 公告编号：2025-047 根据《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司 规范运作》（以下简称"《规范运作》"）、《深圳证券交易所创业板上市公司自律 监管指南第 2 号——公告格式》等有关规定，苏交科集团股份有限公司（以下 简称"公司"或"本公司"）董事会编制了截至 2025 年 6 月 30 日止募集资金年 度存放与使用情况的专项报告。 苏交科集团股份有限公司董事会 关于 2025 年半年度募集资金存放与使用情况的专项报告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、募集资金基本情况 （一）实际募集资金金额、资金到位时间 根据公司第四届董事会第十八次会议、第四届董事会第二十一次会议、 2021 年第一次临时股东大会以及中国证券监督管理委员会证监许可[2021]2731 号文《关于同意苏交科集团股份有限公司向特定对象发行股票注册的批复》同 意注册，公司向特定对象广州珠江实业集团有限公司发行人民币普通股（A 股） 291,421,794股，发行价格为人民币 8.09元/股，募集资金总额为 ...

苏交科集团股份有限公司 2025年半年度非经营性资金占用及其他关联资金往来情况汇总表 编制单位：苏交科集团股份有限公司 单位：人民币元 | 非 经营 | | | | | | | 占 用 方 与 | 上市 公 上市 | 公司 核 算 的 | 202 5年 期 初 往 | 5年 202 来 | 半 年 度 往 | 202 5年 半 年 度 往 | 202 5年 半 年 度 | 偿 202 5年 | 半 年 度 末 | | | 用 性 质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 性 | 资 金 | 占 用 | | | 资 金 占 用 | 方 名 称 | 的 关 联 司 | 关 系 | 会 计 科 目 | 资 金 余 额 | 来 累 计 ( 不 | 发 生金 额 含 利 息) | 来 资 金 的 利 息( 如 有) | 还累 计 发 生金 | 额 往 来 | 资 金 余 额 | 占 用 形 成 原因 | 占 ...

证券代码：300284 证券简称：苏交科 公告编号：2025-044 苏交科集团股份有限公司 第六届监事会第四次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 苏交科集团股份有限公司（以下简称"公司"）第六届监事会第四次会议通知于 2025 年 7 月 16 日以通讯方式向全体监事发出，会议于 2025 年 7 月 26 日在公司会 议室以现场结合通讯表决方式召开。本次会议应出席监事 3 人，实际出席监事 3 人， 其中监事高立先生以通讯方式参会。会议由公司监事会主席刘辉先生主持。本次会 议的召开符合《中华人民共和国公司法》等有关法律、法规和《公司章程》的有关 规定。 二、监事会会议审议情况 经与会监事认真审议，本次会议审议通过了以下议案： （一）审议通过了《2025 年半年度报告》全文及摘要 经审核，监事会认为：董事会编制和审核公司《2025 年半年度报告》全文及摘 要的程序符合法律、法规和中国证监会的有关规定，报告内容真实、准确、完整地 反映了公司 2025 年半年度经营的实际情况，不存在任何虚假记载、误导性陈述或 者 ...

证券代码：300284 证券简称：苏交科 公告编号：2025-043 苏交科集团股份有限公司 第六届董事会第六次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 苏交科集团股份有限公司（以下简称"公司"）第六届董事会第六次会议通知 于 2025 年 7 月 16 日以通讯方式向全体董事发出，会议于 2025 年 7 月 26 日在公 司会议室以现场结合通讯表决方式召开。本次会议应出席董事 9 人，实际出席董 事 9 人，其中董事长李大鹏先生、董事郑洪伟先生、董事吴翔先生、董事韩巍先生 以通讯方式参会。会议由公司董事长李大鹏先生主持，公司全体监事及部分高级管 理人员列席了会议。本次会议的召开符合《中华人民共和国公司法》等有关法律、 法规和《公司章程》的有关规定。 二、董事会会议审议情况 表决结果：同意 9 票，反对 0 票，弃权 0 票。 （二）审议通过了《2025 年半年度募集资金存放与使用情况的专项报告》 公司董事会认为：公司 2025 年半年度募集资金的存放、使用以及募投项目结 项均符合《上市公司监管指引第 2 号——上 ...